Indian pharmaceutical patents in the case of a surge increase in U.S. expiries

Mumbai: In the period between 2010 and 2015, drugs mindboggling $ 157 billion should go to a patent in the U.S., according to industry analysts.
In contrast, in India in 2015 - just when the Indian pharmaceutical market, will cost $ 20 billion - about 15% of drugs that are patented molecules.

70000 Patent applications are in the process and knowledge in this country, "said PH Kurian, Secretary of the controller patents, trademarks and industrial designs.

"From 2005 to date, nearly 13,000 patents were issued in both chemicals and pharmaceuticals," he said.

Accelerated growth in patenting in India in connection with the introduction of patents and a 20-year patent term in 2005, after India signed the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) of the World Trade Organization (WTO) in 1995.

"At that moment there was an adventure, chips went up, and in the future they will continue to grow. In the U.S., although expiries and looks into her eyes, saw dust," said Anuradha Salhotra, managing partner at intellectual property law firm Lall, Lahiri & Salhotra.

At a time when the increasing costs of health care create obstacles to governments around the world, whether India can afford the patented drug questions begging answers.

According to the consulting firm Health Department Technopak, provides the average share of household spending on health is expected to increase from 7% to 13% over the next two decades.

According to K. Keayla, organizer of the National Working Group on Patent Law, patent monopoly money without having to lower prices for generic drugs for exhalation. "The public will suffer as a monopoly of the patent holder to set high prices.

JK CAD, chairman, founder and CEO of the Association of Cancer Care, said that if drastic steps made in making medicines, will be the stage when 90-95% of the population in India will not accept relief funds on account of high prices.

How many people can afford to pay more than 400000 rupees for 24-week training course for Hepatitis C can be patented, said Eldred Tellis, director of Sankalp rehabilitation Trust, Mumbai NGOs working with hepatitis C and AIDS.

"There is a patented medicine for breast cancer price of Rs16 Laja-18 for treatment each year, which seems out of reach of a great nation," says CAD.

Companies have been filing for patents represent various forms of the same drugs, including salt, polymorphic form, analog form, crystalline forms, solid dosage forms, combining the drug with other drugs, etc. (DNA Money, March 5, 2010).

Amit Sengupta, General Secretary of All India Peoples Science Network, said that the number of applications to improve the work of patent offices, and may not be likely to get wrong.